Caspian Pipeline Consortium launches oil pipeline system after planned shutdown-May 2024-www.financetom.com

Caspian Pipeline Consortium launches oil pipeline system after planned shutdown

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Caspian Pipeline Consortium launches oil pipeline system after planned shutdown

Aug 9, 2024 6:08 AM

MOSCOW, Aug 9 (Reuters) - The Caspian Pipeline

Consortium has launched its oil pipeline system after a 62-hour

planned shutdown, CPC said on Friday.

Previous page： Boeing hones $15 billion financing plan to weather crises, sources say Next page： Minerals Technologies Lifts Quarterly Dividend, Sets $200 Million Share Buyback Program

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Boeing hones $15 billion financing plan to weather crises, sources say

Oct 16, 2024

By Shankar Ramakrishnan, Echo Wang and Tim Hepher (Reuters) -Boeing is closing in on a plan to raise around $15 billion with common shares and a mandatory convertible bond as the jetmaker bolsters finances worsened by a crippling strike, but the timing remains unclear, four sources familiar with the matter told Reuters. The company said on Tuesday in regulatory filings...

Minerals Technologies Lifts Quarterly Dividend, Sets $200 Million Share Buyback Program

Oct 16, 2024

05:48 PM EDT, 10/16/2024 (MT Newswires) -- Minerals Technologies ( MTX ) said Wednesday it increased its regular quarterly dividend by 10% to $0.11 per share, payable on Dec. 5 to stockholders of record on Oct. 31. The company also said it has been authorized by its board to buy back $200 million of its shares. ...

BRIEF-Uber Explored Possible Bid For Expedia In 'Super App' Growth Push - FT

Oct 16, 2024

Oct 16 (Reuters) - * UBER EXPLORED POSSIBLE BID FOR EXPEDIA IN 'SUPER APP' GROWTH PUSH - FT Source text for Eikon: https://tinyurl.com/22k9lwp7 Further company coverage: ...

BioCryst Pharmaceuticals' Study of Orladeyo Finds Hospitalization Reduction for Hereditary Angioedema Patients

Oct 16, 2024

08:25 AM EDT, 10/14/2024 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) said Monday a study of berotralstat, which it markets under the brand name of Orladeyo, showed a significant reduction in hospitalizations, emergency room visits, and use of on-demand therapies for patients with hereditary angioedema in the US. The company said that the study of berotralstat will be presented...